東華大學圖書館 |

Development of an Enantioselective Synthesis of (-)-Euonyminol and Studies Towards the Total Synthesis of (-)-Lomaiviticin A /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Development of an Enantioselective Synthesis of (-)-Euonyminol and Studies Towards the Total Synthesis of (-)-Lomaiviticin A // Zhi Xu.
作者:	Xu, Zhi,
面頁冊數:	1 electronic resource (1483 pages)
附註:	Source: Dissertations Abstracts International, Volume: 86-12, Section: B.
Contained By:	Dissertations Abstracts International86-12B.
標題:	Organic chemistry. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31843972
ISBN:	9798286445035

Development of an Enantioselective Synthesis of (-)-Euonyminol and Studies Towards the Total Synthesis of (-)-Lomaiviticin A /
Xu, Zhi,

Development of an Enantioselective Synthesis of (-)-Euonyminol and Studies Towards the Total Synthesis of (-)-Lomaiviticin A /Zhi Xu. - 1 electronic resource (1483 pages)

Source: Dissertations Abstracts International, Volume: 86-12, Section: B.

In the first chapter, I describe the development of the first enantioselective synthesis of (-)-euonyminol (1), a heavily oxidized sesquiterpenoid. Structurally, (-)-euonyminol (1) features a tricyclic framework containing an all-carbon quaternary center and nine free hydroxyl groups. Following the initial failed attempts to achieve a semi-pinacol rearrangement of an allylic silyl ether, we developed a novel oxyalkylation reaction to establish the C10 quaternary center of 1. From this intermediate, we investigated three distinct strategies to construct the tricyclic framework of 1 employing a reductive cyclization, an aldol-dehydration sequence, and a radical cyclization reaction, respectively. Finally, a series of stereoselective transformations provided to (-)-euonyminol (1). Future development based on the route described may lead to the synthesis of other dihydro-β-agarofuran polyesters and macrocyclic terpenoid alkaloids, such as the cathedulins.In the second chapter, I present our investigation into the intramolecular alkene oxyalkylation reaction initially discovered during the synthesis of (-)-euonyminol (1). Our study showed that this reaction is general for a series of 6-oxa-bicyclo[3.2.1]-oct-3-ene derivatives and can proceed competitively with simple carbocyclic substrates. Mechanistic investigation suggested that the extent of charge separation in the transition state governs the product selectivity between cyclopropanation and oxyalkylation pathways. These findings can potentially lead to the development of a more general alkene oxyalkylation reaction.In the third chapter, I provide a comprehensive account of the isolation, structure elucidation, and biological evaluation of the lomaiviticins, a family of complex dimeric bacterial metabolites that contain diazofluorene and 2,6-dideoxy glycoside residues. I then detail MicroED, high-field NMR, and DFT studies that led to the structure revision of the lomaiviticins. In light of the structure revision, I reorganized previously published mechanism of action studies, integrating them with the revised structural assignment of lomaiviticin A (216).In the fourth chapter, I detail the development of a stereocontrolled synthesis of the fully glycosylated monomeric unit of (-)-lomaiviticin A (236). Key features of our synthesis include a decagram-scale synthesis of a naphthoquinone fragment, an alkylation- radical cyclization sequence to construct the tetracyclic framework of 236, and the stereocontrolled installation of the two 2,6-dideoxyglycoside residues employing a β-selective Koenigs-Knorr glycosylation and an α-selective Yu glycosylation, respectively. NMR studies of the synthetic 236 provided additional support for the structure revision. Biological evaluations revealed that 236 is not cytotoxic at concentrations below one micromolar. The route developed established a foundation for accessing other diazo-containing natural product, as well as the dimeric structure of (-)-lomaiviticin A (216).In the fifth chapter, I present our synthetic studies of (-)-lomaiviticin A (216), focusing on the strategies for constructing the bridging carbon-carbon bond. The discussion is organized around three key approaches: reductive dimerization, oxidative dimerization, and an "inside-out" strategy. Progress made, including the stereocontrolled synthesis of the dimeric structure 510, as well as obstacles encountered, are discussed in detail for each route. Finally, I will discuss how these findings can serve as a foundation for refining future synthetic efforts toward the total synthesis of (-)-lomaiviticin A (216), and briefly describe an ongoing synthetic effort.

English

ISBN: 9798286445035Subjects--Topical Terms:

523952
Organic chemistry.
Subjects--Index Terms:

Enantioselective synthesis

Development of an Enantioselective Synthesis of (-)-Euonyminol and Studies Towards the Total Synthesis of (-)-Lomaiviticin A /
LDR:05128nmm a22004453i 4500 001 2433791
005 20250905091014.5
006 m o d
007 cr|nu||||||||
008 261011s2025 miu||||||m |||||||eng d
020 $a 9798286445035
035 $a (MiAaPQD)AAI31843972
035 $a AAI31843972
040 $a MiAaPQD $b eng $c MiAaPQD $e rda
100 1 $a Xu, Zhi, $e author. $3 3823542
245 1 0 $a Development of an Enantioselective Synthesis of (-)-Euonyminol and Studies Towards the Total Synthesis of (-)-Lomaiviticin A / $c Zhi Xu.
264 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2025
300 $a 1 electronic resource (1483 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 86-12, Section: B.
500 $a Advisors: Herzon, Seth B.
502 $b Ph.D. $c Yale University $d 2025.
520 $a In the first chapter, I describe the development of the first enantioselective synthesis of (-)-euonyminol (1), a heavily oxidized sesquiterpenoid. Structurally, (-)-euonyminol (1) features a tricyclic framework containing an all-carbon quaternary center and nine free hydroxyl groups. Following the initial failed attempts to achieve a semi-pinacol rearrangement of an allylic silyl ether, we developed a novel oxyalkylation reaction to establish the C10 quaternary center of 1. From this intermediate, we investigated three distinct strategies to construct the tricyclic framework of 1 employing a reductive cyclization, an aldol-dehydration sequence, and a radical cyclization reaction, respectively. Finally, a series of stereoselective transformations provided to (-)-euonyminol (1). Future development based on the route described may lead to the synthesis of other dihydro-β-agarofuran polyesters and macrocyclic terpenoid alkaloids, such as the cathedulins.In the second chapter, I present our investigation into the intramolecular alkene oxyalkylation reaction initially discovered during the synthesis of (-)-euonyminol (1). Our study showed that this reaction is general for a series of 6-oxa-bicyclo[3.2.1]-oct-3-ene derivatives and can proceed competitively with simple carbocyclic substrates. Mechanistic investigation suggested that the extent of charge separation in the transition state governs the product selectivity between cyclopropanation and oxyalkylation pathways. These findings can potentially lead to the development of a more general alkene oxyalkylation reaction.In the third chapter, I provide a comprehensive account of the isolation, structure elucidation, and biological evaluation of the lomaiviticins, a family of complex dimeric bacterial metabolites that contain diazofluorene and 2,6-dideoxy glycoside residues. I then detail MicroED, high-field NMR, and DFT studies that led to the structure revision of the lomaiviticins. In light of the structure revision, I reorganized previously published mechanism of action studies, integrating them with the revised structural assignment of lomaiviticin A (216).In the fourth chapter, I detail the development of a stereocontrolled synthesis of the fully glycosylated monomeric unit of (-)-lomaiviticin A (236). Key features of our synthesis include a decagram-scale synthesis of a naphthoquinone fragment, an alkylation- radical cyclization sequence to construct the tetracyclic framework of 236, and the stereocontrolled installation of the two 2,6-dideoxyglycoside residues employing a β-selective Koenigs-Knorr glycosylation and an α-selective Yu glycosylation, respectively. NMR studies of the synthetic 236 provided additional support for the structure revision. Biological evaluations revealed that 236 is not cytotoxic at concentrations below one micromolar. The route developed established a foundation for accessing other diazo-containing natural product, as well as the dimeric structure of (-)-lomaiviticin A (216).In the fifth chapter, I present our synthetic studies of (-)-lomaiviticin A (216), focusing on the strategies for constructing the bridging carbon-carbon bond. The discussion is organized around three key approaches: reductive dimerization, oxidative dimerization, and an "inside-out" strategy. Progress made, including the stereocontrolled synthesis of the dimeric structure 510, as well as obstacles encountered, are discussed in detail for each route. Finally, I will discuss how these findings can serve as a foundation for refining future synthetic efforts toward the total synthesis of (-)-lomaiviticin A (216), and briefly describe an ongoing synthetic effort.
546 $a English
590 $a School code: 0265
650 4 $a Organic chemistry. $3 523952
650 4 $a Chemistry. $3 516420
650 4 $a Physical chemistry. $3 1981412
650 4 $a Analytical chemistry. $3 3168300
653 $a Enantioselective synthesis
653 $a Euonyminol
653 $a Lomaiviticin A
653 $a Oxyalkylation reaction
653 $a Radical cyclization reaction
690 $a 0490
690 $a 0486
690 $a 0485
690 $a 0494
710 2 $a Yale University. $b Chemistry. $e degree granting institution. $3 3770408
720 1 $a Herzon, Seth B. $e degree supervisor.
773 0 $t Dissertations Abstracts International $g 86-12B.
790 $a 0265
791 $a Ph.D.
792 $a 2025
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=31843972